Cart
sales@molnova.com
Robustine
CAS No. 2255-50-7
Robustine( —— )
Catalog No. M24028 CAS No. 2255-50-7
Robustine is a natural product, exhibits inhibitory potency against human phosphodiesterase 5 (hPDE5A) in vitro.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 188 | In Stock |
|
| 10MG | 312 | In Stock |
|
| 25MG | 524 | In Stock |
|
| 50MG | 732 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRobustine
-
NoteResearch use only, not for human use.
-
Brief DescriptionRobustine is a natural product, exhibits inhibitory potency against human phosphodiesterase 5 (hPDE5A) in vitro.
-
DescriptionRobustine is a natural product, exhibits inhibitory potency against human phosphodiesterase 5 (hPDE5A) in vitro.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE5A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2255-50-7
-
Formula Weight215.2
-
Molecular FormulaC12H9NO3
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (464.68 mM; Need ultrasonic)
-
SMILESOC1=C2N=C(OC=C3)C3=C(OC)C2=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Neolignans, a coumarinolignan, lignan derivatives, and a chromene: anti-inflammatory constituents from Zanthoxylum avicennae.J Nat Prod. 2008 Feb;71(2):212-7.
molnova catalog
related products
-
PF-04822163
PF-04822163 is a potent inhibitor of PDE1 with IC50 value of 0.0024 μM.
-
Trequinsin hydrochlo...
Trequinsin hydrochloride (HL 725) is a potent, cell-permeable, orally active inhibitor of cGMP-inhibited phosphodiesterase (PCE3 IC50=250 pM).
-
Ensifentrine
Ensifentrine is a PDE3/4 inhibitor, although its affinity for PDE3(IC50: 0.4 nM) is 3,440 times higher than that for PDE4(IC50: 1479 nM), that is under clinical development for the treatment of asthma and COPD and, potentially, cystic fibrosis.
